Skip to content
Search

Latest Stories

Survey finds most Britons reject Covid-19 'vaccine nationalism'

Most Britons reject Covid-19 “vaccine nationalism”, and say they would be willing to wait until health workers in other countries have had vaccines if that would help end the pandemic sooner, according to poll findings released on Monday.

Conducted in mid-August by polling firm Savanta ComRes for anti-poverty organisation The ONE Campaign, the survey found significant public support for Covid-19 vaccines being made available to all countries at the same time, regardless of how rich or powerful they are.


“British people clearly understand this global pandemic demands a global response. It simply won’t work for each country to go its own way,” said Romilly Greenhill, The ONE’s UK director.

“While this virus thrives anywhere, it threatens people everywhere.”

The World Health Organization called last week for an end to “vaccine nationalism” and warned against “hoarding” as a growing number of countries agreed bilateral deals to buy millions of doses of Covid-19 vaccines.

The One Campaign poll results found that of more than 2,000 people surveyed, 82 per cent said a country that develops a Covid-19 vaccine should share that knowledge, and 76 per cent think Covid-19 shots should be available in all countries at the same time.

More than 80 per cent think that when a Covid-19 vaccine is available, it should be distributed in the most effective way to beat the pandemic globally. Some 71 per cent think that if it means the pandemic could be ended more quickly, health workers in Britain and then other countries should get vaccines first, even if healthy people at home have to wait a bit longer.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less